divis
beat cent lower estim
march adjust ep cent vs cent year earlier cent higher
estim sale million model better expect
ep estim held back equip
inventori reduct distributor first half year sale market invest
grow digit dentistri initi dilut acquir orametrix
ep estim project
lead world-wide dental product manufactur report march adjust ep
cent vs cent last year compar report year-over-year period yoy unless otherwis
indic cent higher estim pre-tax basi exclud adjust ep million
intang amort million restructur cost million gain sale market
secur million fair valu adjust
sale million project exclud preciou metal pm content million vs
million normal impact commod gold/silv price show sale exclud pm
earn model separ line item sale yoy million sale fell organ basi
acquisit ad bp fx ad bp
consum ex-pm sale intern neg affect order pull forward
improv recent month equip fell impact
approxim million dealer inventori reduct vs last quarter driven
declin segment europ vs almost entir due weaken dollar
equip sale face tough comparison last year intern dental show row rose vs
organ aid segment region
gross margin vs sg expens increas revenu vs adjust
oper profit million decreas bp yoy ex-pm sale net interest
adjust expens flat million adjust tax rate around vs adjust
net incom million fell yoy ex-pm net profit margin bp yoy sale
pleas see import disclosur end report
balanc sheet march show cash equival million account receiv rose
yoy vs sale increas million dso flat inventori yoy
million day calcul month data vs total debt around billion
compar equiti billion debt-to-tot capit ratio vs year earlier high
septemb acquisit astratech compani target net cash
ratio
flow oper cfo million vs million year earlier free cash flow
priorit order import reinvest busi accret stock buyback
dividend rais februari per quarter share repurchas quarter
april dentspli board increas share repurchas author million bring total
author billion
dentspli acquir orametrix lead industri provid technolog solut orthodont may
purchas price million potenti earn-out payment addit million
orametrix gener annual revenu around million januari fda grant pre-market
approv orametrix sureclear align system sureclear allow dentspli better compet align
technolog cover domin approxim billion clear align market
invisalign product complementari product sureclear could pair dentspli omnicam digit
impress tool acquisit dentspli comprehens orthodont offer includ
plan softwar imag bracket wire well clear align therefor abl offer
appropri solut dentist/pati acquisit dilut ep cent
per share invest grow busi
sale earn outlook
dentspli continu target million annual cost save area procur
ration manufactur footprint make oper model effici indic
track achiev million sale impact million target inventori channel
reduct expect first half sale million realiz growth
region expect pick dentspli close de plain il handpiec
manufactur facil move much larger handpiec facil bensheim germani
compani expect complet consolid german distribut facil european
distribut hub netherland addit consolid compani lancast pa distribut
center on-going dentspli creat new program facilit cross sell
previous mention dentspli enter three-year agreement distributor henri schein
went effect septemb distribut compani full line dental equip north america
addit product alreadi offer dentspli imag equip abl integr
dentist practic manag softwar could help boost sale back half year
dentspli also recent negoti long-term agreement previous
equip exclus distributor access full line dentspli product agreement
ultim help dentspli drive adopt single-visit dentistri cerec system
around penetr germani imag even less dentspli ad sale rep
rank ensur custom product demonstr speedili schedul deal close
june ep estim cent vs cent year earlier cent previous top line
billion ex-pm vs billion
ep estim vs record adjust compani reduc
guidanc previous revenu billion vs
pleas see import disclosur end report
divis wellington shield co llc
corpor
billion compani guidanc around billion organ growth rate target rest
orametrix expect reduc ep cent lower sale invest stronger sale
market program dentspli global salespeopl anticip
cent neg impact tax rate benefit year approxim cent compani guidanc
includ potenti buyback recent growth invest take month materi
benefit start back half compani indic robust pipelin new
product plan margin expect bp versu forecast oper
net margin ex-pm revenu respect vs respect
upcom chang dentspli leadership implant could improv result categori
compani see sign life tax rate model vs new tax law reduc
valu dentspli foreign tax credit impact cent per share capit spend estim around
million exclud amort purchas intang around million
million dividend million result gross/fre cash flow per share
ep estim project revenu billion
assum progress initi note includ greater use cerec omnicam base
dentspli strategi better compet digit impress space forecast oper margin
ex-pm revenu net interest expens model million tax rate net
margin project bp ex-pm revenu net incom ep forecast
share count model slightli
share sell forward ep estim project
year ep growth rate rate hold share trade trail price-to-report
earn ratio current sell estim ebitda
million around estim ebitda billion short posit million share
april equal days-to-cov base averag daili volum day million share
realiz expect revenue/cost synergi sirona major risk compound recent
manag chang middl integr compani report investig
sec divis enforc regard account disclosur worth note pwc
compani auditor sign financi statement without request extens scrutin
report impact econom condit includ job loss procedur deferr trade-down
result risk sale outsid compani expos fx
fluctuat well effect sale forc abl satisfactorili servic countri gener
reimburs concern impact result signific impact outsid
particularli germani limit reimburs domest anoth consider regulatori
environ includ fda regul introduct manufactur advertis label packag
market distribut product
pleas see import disclosur end report
divis wellington shield co llc
-- earn model -- may
dec year-end
million except per share data
good sold
good sold
pleas see import disclosur end report
